Sponsor:
Viking Therapeutics, Inc.
Code:
NCT07868939
Conditions
Weight Loss
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
VK2735 Oral
Placebo Comparator
Brief summary:
Conditions
Weight Loss
Study ID
NCT07868939
Start date
Nov, 2026
Status verified date
Nov, 2026
Completion date
Dec, 2028
Anticipated
Primary completion date
Oct, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
560 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
placebo comparator: Placebo Assignment
experimental: Active Assignment (Dose 1)
experimental: Active Assignment (Dose 2)
experimental: Active Assignment (Dose 3)
Interventions
VK2735 Oral
Placebo Comparator
Primary outcome measure
Central contacts
Locations
Viking Clinical Site #2015
Recruiting
Lake Forest, California, United States, 92630
Contacts
Viking Clinical Site #2046
Recruiting
Indianapolis, Indiana, United States, 46202
Contacts
Viking Clinical Site #2028
Recruiting
Springfield, Missouri, United States, 65807
Contacts
Viking Clinical Site #2052
Recruiting
Albuquerque, New Mexico, United States, 87107
Contacts
Viking Clinical Site #2002
Recruiting
East Greenwich, Rhode Island, United States, 02818
Contacts
Viking Clinical Site #2044
Recruiting
Charleston, South Carolina, United States, 29407
Contacts
Viking Clinical Site #2030
Recruiting
Hendersonville, Tennessee, United States, 37075
Contacts
Sponsor
Viking Therapeutics, Inc.
Last update posted
Nov 16, 2026
Last verified
Nov, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-17. This information was provided to ClinicalTrials.gov by Viking Therapeutics, Inc. on 2026-11-16. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.